Clinical trial
Budesonide Inhalation Suspension for Acute Asthma in Children
NCT00393367 · Children's Hospital of Philadelphia, Other · Completed
Key facts
| NCT number | NCT00393367 |
|---|---|
| Title | Budesonide Inhalation Suspension for Acute Asthma in Children |
| Official title | Budesonide Inhalation Suspension for Acute Asthma in Children |
| Lead sponsor | Children's Hospital of Philadelphia, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma, Acute Asthma, Reactive Airway Exacerbation |
| Intervention type | Drug |
| Interventions | Budesonide inhalation suspension (0.5 mg/2mL) 2mg, albuterol (5mg/mL) 7.5 or 10mg, Prednisolone, prednisone, or methylprednisolone, Albuterol, ipratropium bromide, Ipratropium bromide |
| Enrollment | 179 |
| Start date | Dec 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Oct 27, 2006 |
| Last update posted | Aug 10, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: